The Non-invasive Prenatal Test - Pro (NIPT - Pro) screens for common chromosomal conditions using a simple maternal blood sample. It detects Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome), along with Sex Chromosome Aneuploidies such as Turner syndrome and Klinefelter syndrome. The test also includes fetal gender determination, reports incidental findings related to chromosomal variations, and screens for 92 clinically significant microdeletions and duplications. Safe and highly accurate, NIPT - Pro can be performed as early as the 10th week of pregnancy, providing parents with comprehensive genetic insights to support informed decision-making.
A medical professional will collect a blood sample from the expecting mother at our partner clinic, which will then be sent to our partner clinic's laboratory for analysis. Once the test is complete, the results will be securely emailed to the registered client.